NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31/01/2025
Voltar para busca
Dado oficial do USPTO
LIPAD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
25/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
18/03/2016
Data de registro
28/05/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/01/2025
Última transação
25/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Taipei City 11503, TW
Examinador
HESIK, APRIL
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
TAIWAN LIPOSOME CO., LTD.
Representantes
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; lipid-based preparations for medical or clinical use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use
Classe 42
Biochemical research and development; biomedical research services; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; chemicalbiochemicalbiological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific researchconducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
31/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/01/2025
E815
TEAS SECTION 8 & 15 RECEIVED
16/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
28/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2019
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/02/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
29/01/2019
OTHE
CASE RETURNED TO EXAMINATION
28/01/2019
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
22/01/2019
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
22/01/2019
IUCN
NOTICE OF ALLOWANCE CANCELLED
14/01/2019
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
14/01/2019
PILM
PETITION INQUIRY LETTER ISSUED
14/01/2019
APET
ASSIGNED TO PETITION STAFF
14/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/11/2018
EX3G
SOU EXTENSION 3 GRANTED
02/11/2018
EXT3
SOU EXTENSION 3 FILED
02/11/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/11/2018
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
02/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/05/2018
EX2G
SOU EXTENSION 2 GRANTED
16/05/2018
EXT2
SOU EXTENSION 2 FILED
16/05/2018
EEXT
SOU TEAS EXTENSION RECEIVED
16/05/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/11/2017
EX1G
SOU EXTENSION 1 GRANTED
16/11/2017
EXT1
SOU EXTENSION 1 FILED
16/11/2017
EEXT
SOU TEAS EXTENSION RECEIVED
16/11/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/03/2017
PUBO
PUBLISHED FOR OPPOSITION
21/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/01/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2017
ALIE
ASSIGNED TO LIE
20/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/12/2016
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
12/09/2016
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
12/09/2016
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
12/09/2016
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/09/2016
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/09/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/06/2016
GNRT
NON-FINAL ACTION E-MAILED
28/06/2016
CNRT
NON-FINAL ACTION WRITTEN
28/06/2016
DOCK
ASSIGNED TO EXAMINER
28/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/03/2016
NWAP
NEW APPLICATION ENTERED
22/03/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIPAD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.